Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Redhill Biopharma has received a decision to grant European patent number EP3359255 titled "COMBINATION THERAPIES FOR TREATING CANCER ".

Author: Benzinga Newsdesk | July 17, 2025 02:59pm

https://register.epo.org/application?number=EP16853154

Posted In: RDHL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist